Molina Healthcare Stock
€165.85
Your prediction
Molina Healthcare Stock
Pros and Cons of Molina Healthcare in the next few years
Pros
Cons
Performance of Molina Healthcare vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Molina Healthcare | -0.300% | 11.048% | 44.469% | -42.533% | 13.596% | -38.665% | -20.798% |
| Chemed Corp. | - | 10.429% | 11.111% | -28.713% | -1.099% | - | - |
| Select Medical Holdings | - | 0.730% | -0.719% | -10.390% | 10.400% | -48.889% | -56.051% |
| Davita Inc. | -0.150% | -0.377% | -0.602% | 5.802% | 37.080% | 61.180% | 36.345% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Molina Healthcare (MOH) showcases a robust financial structure and operational efficiency within the healthcare services sector, demonstrating solid growth, strategic management of resources, and value generation for shareholders. An overall positive impression emerges from the examination of their balance sheets, cash flow statements, income statements, and financial ratios. However, like any business, it does encounter certain challenges, which must be weighed against its strengths.
Pros of Molina Healthcare's Financials
Strong Revenue Growth: Molina Healthcare has experienced substantial revenue growth, exemplified by an increase from $27.77 billion in 2021 to approximately $36.08 billion in the trailing twelve months (TTM) for 2023. This increase indicates effective market capture and a rising client base, which is critical in the competitive healthcare provider landscape.
Comments
News
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Molina Healthcare
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH) and reminds investors of the
